Drug eluting stents based on Poly(ethylene carbonate): Optimization of the stent coating process

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 3, 2012, Pages 562-570

  Bege, Nadja ^a   Steinmüller, Sven Ole ^b   Kalinowski, Marc ^c   Reul, Regina ^a   Klaus, Sebastian ^d   Petersen, Holger ^e   Curdy, Catherine ^e   Janek, Jürgen ^b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

^d eucatech AG   (Germany)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

DES; Late stent thrombosis; Paclitaxel; PEC; Spray coating; TOF SIMS

Indexed keywords

ETHYLENE OXIDE; FLUORESCENT DYE; PACLITAXEL; POLY(ETHYLENE CARBONATE); POLYMER; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CONFOCAL LASER MICROSCOPY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG ELUTING STENT; DRUG RELEASE; MACROPHAGE; MASS SPECTROMETRY; MATERIAL COATING; MOLECULAR WEIGHT; NEUTROPHIL; TIME OF FLIGHT SECONDARY MASS SPECTROMETRY;

ABSORBABLE IMPLANTS; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG-ELUTING STENTS; ETHYLENE OXIDE; EXCIPIENTS; KINETICS; PACLITAXEL; POLYETHYLENES; POLYMERS; THROMBOSIS;

EID: 84858155788     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.12.006     Document Type: Article

References (38)

1. N.D. Lambert, and R.J. Applegate The comparative safety of bare-metal and drug-eluting intracoronary stents Expert Rev. Med. Dev. 7 5 2010 611 624
2. R. Hirlekar, M. Patel, S. Jain, and V. Kadam Drug eluting coronary artery stents Curr. Drug. Deliv. 7 2010 421 427
3. J.V. Llau, R. Ferrandis, P. Sierra, and A. Gomez-Luque Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update Vasc. Health Risk Manage. 6 2010 855 867
4. A. Abizaid, and J.R. Costa Jr. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems Circ. Cardiovasc. Interv 3 4 2010 384 393
5. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 17 2007 2344 2351 (Pubitemid 46685903)
6. A. Farb, A.P. Burke, F.D. Kolodgie, and R. Virmani Pathological mechanisms of fatal late coronary stent thrombosis in humans Circulation 108 14 2003 1701 1706 (Pubitemid 37243657)
7. G. Nakazawa, A.V. Finn, M. Vorpahl, E.R. Ladich, F.D. Kolodgie, and R. Virmani Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents J. Am. Coll. Cardiol. 57 4 2011 390 398
8. G.V. Silva, M.R. Fernandes, R. Madonna, F. Clubb, E. Oliveira, P. Jimenez-Quevedo, R. Branco, J. Lopez, F.S. Angeli, R. Sanz-Ruiz, W.K. Vaughn, Y. Zheng, F. Baimbridge, J. Canales, C.O. Cardoso, J.A. Assad, R. Falotico, and E.C. Perin Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis Catheter Cardiovasc. Interv. 73 6 2009 801 808
9. T.F. Luscher, J. Steffel, F.R. Eberli, M. Joner, G. Nakazawa, F.C. Tanner, and R. Virmani Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 8 2007 1051 1058 (Pubitemid 46328299)
10. R. Wessely New drug-eluting stent concepts Nat. Rev. Cardiol. 7 4 2010 194 203
11. M. Dadsetan, E.M. Christenson, F. Unger, M. Ausborn, T. Kissel, A. Hiltner, and J.M. Anderson In vivo biocompatibility and biodegradation of poly(ethylene carbonate) J. Control. Release 93 3 2003 259 270 (Pubitemid 37485948)
12. F. Unger, U. Westedt, P. Hanefeld, R. Wombacher, S. Zimmermann, A. Greiner, M. Ausborn, and T. Kissel Poly(ethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings? J. Control. Release 117 3 2007 312 321 (Pubitemid 46216577)
13. G.H. Stoll, F. Nimmerfall, M. Acemoglu, D. Bodmer, S. Bantle, I. Muller, A. Mahl, M. Kolopp, and K. Tullberg Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents J. Control. Release 76 3 2001 209 225 (Pubitemid 32913431)
14. N.A. Scott Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury Adv. Drug Delivery Rev. 58 3 2006 358 376 (Pubitemid 43816739)
15. R. Jabara, N. Chronos, D. Conway, W. Molema, and K. Robinson Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating JACC Cardiovasc. Interv. 1 1 2008 81 87 (Pubitemid 351445424)
16. M. Acemoglu, F. Nimmerfall, S. Bantle, and G.H. Stoll Poly(ethylene carbonate)s, part I: syntheses and structural effects on biodegradation J. Control. Release 49 2,3 1997 263 275
17. C. Schmidt, V. Stuempflen, J.H. Wendorff, A. Hasenhindl, W. Gronski, M. Ishaque, and A. Greiner Structural analysis of poly(p-xylylene) (PPX) prepared by vapor phase pyrolysis of [2.2]paracyclophane Acta Polym. 49 5 1998 232 235 (Pubitemid 128728983)
18. K.R. Kamath, J.J. Barry, and K.M. Miller The Taxus drug-eluting stent: a new paradigm in controlled drug delivery Adv. Drug Delivery Rev. 58 3 2006 412 436 (Pubitemid 43949060)
19. G. Acharya, and K. Park Mechanisms of controlled drug release from drug-eluting stents Adv. Drug Delivery Rev. 58 3 2006 387 401 (Pubitemid 43816741)
20. U. Westedt, M. Wittmar, M. Hellwig, P. Hanefeld, A. Greiner, A.K. Schaper, and T. Kissel Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings J. Control. Release 111 1-2 2006 235 246 (Pubitemid 43290013)
21. J. Pan Ch, J.J. Tang, Y.J. Weng, J. Wang, and N. Huang Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents J. Control. Release 116 1 2006 42 49 (Pubitemid 44792298)
22. L. Indolfi, F. Causa, and P.A. Netti Coating process and early stage adhesion evaluation of poly(2-hydroxy-ethyl-methacrylate) hydrogel coating of 316L steel surface for stent applications J. Mater. Sci.: Mater. Med. 20 7 2009 1541 1551
23. E. Kang, K. Vedantham, X. Long, M. Dadara, I.K. Kwon, M. Sturek, and K. Park Drug-eluting stent for delivery of signal pathway-specific 1, 3-dipropyl-8-cyclopentyl xanthine Mol. Pharm. 6 4 2009 1110 1117
24. Y. Levy, D. Mandler, J. Weinberger, and A.J. Domb Evaluation of drug-eluting stents' coating durability-clinical and regulatory implications J. Biomed. Mater. Res. B Appl. Biomater. 91 1 2009 441 451
25. E. Grube, J. Schofer, K.E. Hauptmann, G. Nickenig, N. Curzen, D.J. Allocco, and K.D. Dawkins A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent JACC Cardiovasc. Interv. 3 4 2010 431 438
26. R. Wessely, B. Blaich, R.S. Belaiba, S. Merl, A. Gorlach, A. Kastrati, and A. Schomig Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery Thromb. Haemost. 97 6 2007 1003 1012 (Pubitemid 46939215)
27. G. Guagliumi, V. Sirbu, G. Musumeci, H.G. Bezerra, A. Aprile, H. Kyono, L. Fiocca, A. Matiashvili, N. Lortkipanidze, A. Vassileva, J.J. Popma, D.J. Allocco, K.D. Dawkins, O. Valsecchi, and M.A. Costa Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI) Circ. Cardiovasc. Interv. 3 4 2010 367 375
28. S. Garg, and P.W. Serruys Coronary stents: looking forward J. Am. Coll. Cardiol. 56 10 2010 S43 78 SUPPL.
29. Monographs: Paclitaxel, European Pharmacopoiea Edition 7.2, 2011.
30. M. Gagliardi, D. Silvestri, C. Cristallini, M. Guadagni, G. Crifaci, and P. Giusti Combined drug release from biodegradable bilayer coating for endovascular stents J. Biomed. Mater. Res. B Appl. Biomater. 93 2 2010 375 385
31. M. Boden, R. Richard, M.C. Schwarz, S. Kangas, B. Huibregtse, and J.J. Barry In vitro and in vivo evaluation of the safety and stability of the TAXUS Paclitaxel-Eluting Coronary Stent J. Mater. Sci. Mater. Med. 20 7 2009 1553 1562
32. S.V. Ranade, K.M. Miller, R.E. Richard, A.K. Chan, M.J. Allen, and M.N. Helmus Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent J. Biomed. Mater. Res. A 71 4 2004 625 634 (Pubitemid 39578676)
33. E. Kang, H. Wang, I.K. Kwon, Y.H. Song, K. Kamath, K.M. Miller, J. Barry, J.X. Cheng, and K. Park Application of coherent anti-Stokes Raman scattering microscopy to image the changes in a paclitaxel-poly(styrene-b-isobutylene-b- styrene) matrix pre- and post-drug elution J. Biomed. Mater. Res. A 87 4 2008 913 920
34. N. Bege, T. Renette, M. Jansch, R. Reul, O. Merkel, H. Petersen, C. Curdy, R.H. Muller, and T. Kissel Biodegradable Poly(ethylene carbonate) nanoparticles as a promising drug delivery system with "stealth" potential Macromol. Biosci. 11 7 2011 897 904
35. L.L. Lao, and S.S. Venkatraman Paclitaxel release from single and double-layered poly(dl-lactide-co-glycolide)/poly(l-lactide) film for biodegradable coronary stent application J. Biomed. Mater. Res. A 87 1 2008 1 7
36. A.V. Finn, G. Nakazawa, M. Joner, F.D. Kolodgie, E.K. Mont, H.K. Gold, and R. Virmani Vascular responses to drug eluting stents: importance of delayed healing Arterioscler. Thromb. Vasc. Biol. 27 7 2007 1500 1510 (Pubitemid 46986103)
37. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 11 2007 1440 1455 discussion 1455 (Pubitemid 46648381)
38. D.J. Kereiakes, L.A. Cannon, R.L. Feldman, J.J. Popma, R. Magorien, R. Whitbourn, I.M. Dauber, A.C. Rabinowitz, M.W. Ball, B. Bertolet, A. Kabour, M.C. Foster, J.C. Wang, P. Underwood, and K.D. Dawkins Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial J. Am. Coll. Cardiol. 56 4 2010 264 271